- Home
- NBY vs INAB Comparison
NBY vs INAB Comparison
Compare NBY & INAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBY
- INAB
- Stock Information
- Founded
- NBY 2000
- INAB 2016
- Country
- NBY United States
- INAB United States
- Employees
- NBY N/A
- INAB N/A
- Industry
- NBY
- INAB Biotechnology: Pharmaceutical Preparations
- Sector
- NBY
- INAB Health Care
- Exchange
- NBY Nasdaq
- INAB Nasdaq
- Market Cap
- NBY 3.5M
- INAB N/A
- IPO Year
- NBY 2007
- INAB 2021
- Fundamental
- Price
- NBY $0.71
- INAB $0.26
- Analyst Decision
- NBY
- INAB Strong Buy
- Analyst Count
- NBY 0
- INAB 3
- Target Price
- NBY N/A
- INAB $10.00
- AVG Volume (30 Days)
- NBY 7.7M
- INAB 289.4K
- Earning Date
- NBY 11-07-2024
- INAB 11-07-2024
- Dividend Yield
- NBY N/A
- INAB N/A
- EPS Growth
- NBY N/A
- INAB N/A
- EPS
- NBY N/A
- INAB N/A
- Revenue
- NBY $13,884,000.00
- INAB N/A
- Revenue This Year
- NBY N/A
- INAB N/A
- Revenue Next Year
- NBY $26.04
- INAB N/A
- P/E Ratio
- NBY N/A
- INAB N/A
- Revenue Growth
- NBY 4.06
- INAB N/A
- 52 Week Low
- NBY $0.36
- INAB $0.24
- 52 Week High
- NBY $15.40
- INAB $2.48
- Technical
- Relative Strength Index (RSI)
- NBY 55.65
- INAB 24.37
- Support Level
- NBY $0.64
- INAB $0.24
- Resistance Level
- NBY $0.71
- INAB $0.29
- Average True Range (ATR)
- NBY 0.08
- INAB 0.02
- MACD
- NBY 0.02
- INAB 0.01
- Stochastic Oscillator
- NBY 43.40
- INAB 23.95
About NBY NovaBay Pharmaceuticals Inc.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically eyecare and skincare products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease. It has two reportable segments: Eyecare and Wound Care and Skincare.